Literature DB >> 23986600

Role of interleukin-2 and herpes simplex virus 1 in central nervous system demyelination in mice.

Kevin R Mott1, Mandana Zandian, Sariah J Allen, Homayon Ghiasi.   

Abstract

We have reported previously that ocular infection of different strains of mice with recombinant herpes simplex virus 1 (HSV-1) constitutively expressing interleukin-2 (IL-2) provokes central nervous system (CNS) demyelination and optic neuropathy, as determined by changes in visual evoked cortical potentials and pathological changes in the optic nerve and CNS, whereas recombinant viruses expressing IL-4, gamma interferon, IL-12p35, IL-12p40, or IL-12p70 do not induce this neuropathy. The goal of this study was to dissect the mechanism underlying the interplay between the immune system (elevation of IL-2) and an environmental factor (infection with HSV-1) that elicits this pathology. Similar results were obtained upon delivery of IL-2 into the mouse brain using osmotic minipumps or injection of mice with recombinant IL-2 protein, IL-2 DNA, or IL-2 synthetic peptides prior to infection with wild-type (wt) HSV-1 strains McKrae and KOS. The critical role of IL-2 is further supported by our data, indicating that a single mutation at position T27A in IL-2 completely blocks the HSV-1-induced pathology. This study shows a novel model of autoimmunity in which viral infection and enhanced IL-2 cause CNS demyelination.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23986600      PMCID: PMC3807926          DOI: 10.1128/JVI.02241-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Correlation of immunological studies and disease progression in chronic progressive multiple sclerosis.

Authors:  J L Trotter; D B Clifford; J E McInnis; R C Griffeth; K A Bruns; M S Perlmutter; C B Anderson; K G Collins; G Banks; B C Hicks
Journal:  Ann Neurol       Date:  1989-02       Impact factor: 10.422

2.  Serum soluble interleukin-2 receptor levels in chronic progressive, stable and steroid-treated multiple sclerosis.

Authors:  S Bansil; R Troiano; S D Cook; C Rohowsky-Kochan
Journal:  Acta Neurol Scand       Date:  1991-10       Impact factor: 3.209

3.  Interleukin-2 receptor levels indicating relapse in multiple sclerosis.

Authors:  K Adachi; T Kumamoto; S Araki
Journal:  Lancet       Date:  1989-03-11       Impact factor: 79.321

4.  Elevated levels of soluble interleukin-2 receptors in multiple sclerosis.

Authors:  S J Greenberg; L Marcon; B J Hurwitz; T A Waldmann; D L Nelson
Journal:  N Engl J Med       Date:  1988-10-13       Impact factor: 91.245

5.  Soluble interleukin-2 receptors in cerebrospinal fluid from individuals with various neurological disorders.

Authors:  S D Kittur; D S Kittur; T T Soncrant; S I Rapoport; W W Tourtellotte; J E Nagel; W H Adler
Journal:  Ann Neurol       Date:  1990-08       Impact factor: 10.422

6.  Immune activation in multiple sclerosis: study of IL-2, sIL-2R, and gamma-IFN levels in serum and cerebrospinal fluid.

Authors:  P Gallo; M G Piccinno; S Pagni; V Argentiero; B Giometto; F Bozza; B Tavolato
Journal:  J Neurol Sci       Date:  1989-08       Impact factor: 3.181

7.  Role of coexpression of IL-2 and herpes simplex virus proteins in recombinant vaccinia virus vectors on levels of induced immunity.

Authors:  E M Allen; J P Weir; S Martin; C Mercadal; B T Rouse
Journal:  Viral Immunol       Date:  1990       Impact factor: 2.257

8.  T cell activation in Guillain-Barré syndrome and in MS: elevated serum levels of soluble IL-2 receptors.

Authors:  H P Hartung; R A Hughes; W A Taylor; K Heininger; K Reiners; K V Toyka
Journal:  Neurology       Date:  1990-02       Impact factor: 9.910

9.  Multiple sclerosis: effect of myelin basic protein on interleukin 1, interleukin 2 production and interleukin 2 receptor expression in vitro.

Authors:  K Selmaj; Z Nowak; H Tchórzewski
Journal:  Clin Exp Immunol       Date:  1988-06       Impact factor: 4.330

10.  Mouse interleukin-2 structure-function studies: substitutions in the first alpha-helix can specifically inactivate p70 receptor binding and mutations in the fifth alpha-helix can specifically inactivate p55 receptor binding.

Authors:  S M Zurawski; G Zurawski
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

View more
  9 in total

1.  Type 2 Innate Lymphoid Cells Induce CNS Demyelination in an HSV-IL-2 Mouse Model of Multiple Sclerosis.

Authors:  Satoshi Hirose; Pedram Shafiei Jahani; Shaohui Wang; Ujjaldeep Jaggi; Kati Tormanen; Jack Yu; Mihoko Kato; Omid Akbari; Homayon Ghiasi
Journal:  iScience       Date:  2020-09-10

2.  Impact of a Demyelination-Inducing Central Nervous System Virus on Expression of Demyelination Genes in Type 2 Lymphoid Cells.

Authors:  Satoshi Hirose; Mihoko Kato; Kati Tormanen; Pedram Shafiei Jahani; Omid Akbari; Homayon Ghiasi
Journal:  J Virol       Date:  2021-01-28       Impact factor: 5.103

3.  Novel treatment with neuroprotective and antiviral properties against a neuroinvasive human respiratory virus.

Authors:  Elodie Brison; Hélène Jacomy; Marc Desforges; Pierre J Talbot
Journal:  J Virol       Date:  2013-11-13       Impact factor: 5.103

4.  A comparative study of experimental mouse models of central nervous system demyelination.

Authors:  O M Dumitrascu; K R Mott; H Ghiasi
Journal:  Gene Ther       Date:  2014-04-10       Impact factor: 5.250

5.  Suppression of IL-12p70 formation by IL-2 or following macrophage depletion causes T-cell autoreactivity leading to CNS demyelination in HSV-1-infected mice.

Authors:  Dhong Hyun Lee; Mandana Zandian; Jane Kuo; Kevin R Mott; Shuang Chen; Moshe Arditi; Homayon Ghiasi
Journal:  PLoS Pathog       Date:  2017-05-22       Impact factor: 6.823

Review 6.  The Role of Herpes Simplex Virus Type 1 Infection in Demyelination of the Central Nervous System.

Authors:  Raquel Bello-Morales; Sabina Andreu; José Antonio López-Guerrero
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

Review 7.  Herpes Simplex Virus Type 1 Infection of the Central Nervous System: Insights Into Proposed Interrelationships With Neurodegenerative Disorders.

Authors:  Luisa F Duarte; Mónica A Farías; Diana M Álvarez; Susan M Bueno; Claudia A Riedel; Pablo A González
Journal:  Front Cell Neurosci       Date:  2019-02-26       Impact factor: 5.505

8.  Protocol for a mouse CNS demyelination model induced by a combination of HSV-1 and IL-2.

Authors:  Satoshi Hirose; Kati Tormanen; Mihoko Kato; Jack Yu; Homayon Ghiasi
Journal:  STAR Protoc       Date:  2021-01-19

9.  Herpes simplex virus, early neuroimaging markers and incidence of Alzheimer's disease.

Authors:  Morgane Linard; Marion Baillet; Luc Letenneur; Isabelle Garrigue; Gwenaëlle Catheline; Jean-François Dartigues; Karine Peres; Catherine Helmer
Journal:  Transl Psychiatry       Date:  2021-07-31       Impact factor: 6.222

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.